Hadassah

Hadassah Specialists Conduct Clinical Trial Using Deep Brain Stimulation to Relieve Depression

Thursday, Sep 27 2012

A multidisciplinary team at the Hadassah Medical Center is testing the use of Deep Brain Stimulation (DBS) to alleviate depression in severely affected patients.

The Hadassah team includes physicians from Neurosurgery, Psychiatry, the Biological Psychiatry Laboratory, the Medical Neurobiology Department, and the Center for Functional and Restorative Surgery. The experimental procedure is part of an international clinical trial being conducted in several European countries and Israel. In order to be accepted into the study, patients must have already tried at least three different drug treatments as well as electro-convulsive therapy and failed to attain relief.

The treatment involves the insertion of two electrodes into symmetrical areas of the brain, known to affect mood regulation. “There is evidence of increased activity in these areas among the severely depressed,” explains Prof. Benjamin Lerer, head of the Biological Psychiatry Laboratory. The electric current, he relates, reduces that activity and gradually affects the patient’s mood.

The electrodes, in turn, are connected to filaments that are implanted under the scalp, reaching to the chest wall where the operating unit—a computer and a battery—are implanted. Dr. Zvi Israel, Director of the Center for Functional and Restorative Surgery, reports that they have found that “treating the severely depressed with DBS has a 70 percent success rate.”

DBS has been used to treat obsessive-compulsive disorder since 2009 and Parkinson’s severe tremors since 2002.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More